Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone versus hydrocortisone replacement therapy for nocturnal hypoglycaemia in type 1 diabetes with adrenal insufficiency
2008-002336-15Phase 4Terminated
- Sponsor
- King's College London
- Start
- May 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prednisolone and hydrocortisone in hypoadrenocorticism (2 arms), sponsored by King's College London. Primary endpoint: Frequency of moderate nocturnal biochemical hypoglycaemia. Started May 2011; status: terminated.
02
Drugs
prednisolonehydrocortisone
03
Conditions
hypoadrenocorticism
Beyond the preview
Go deeper on 2008-002336-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002336-15.